Printer-friendly version


What we've been up to lately

Donation Program - Gilead Access Program®

HIV/AIDS Donation Management with Gilead
January 2003
Donation Program - Gilead Access Program®

The Gilead Access Program is designed to expand sustainable access to the once-daily anti-HIV medications Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Viread® (tenofovir disoproxil fumarate) in 97 developing countries.

The Program is one in a series of donations programs based on methods we helped develop. MCART provided all systems, data design, programming, front end work, and much conceptual planning.


©1997-2025 MCART|design + programming mcart group|Updated: 2021-06-23 16:43 GMT|